AstraZeneca, Oxford aim to produce Omicron-targeted vaccine

AstraZeneca, Oxford aim to produce Omicron-targeted vaccine A lab-study last week found that AstraZeneca's antibody cocktail Evusheld retained neutralising activity against the Omicron variant. https://ift.tt/eA8V8J